M. Kneissel
Molecular Biology · 2005–2013
A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 2 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 43 citations into it; #12,759 of 17,773 by trust here, #11,207 by citations
Whom M. Kneissel trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts M. Kneissel overall
Papers from M. Kneissel's perspective
Ordered by how strongly the researchers M. Kneissel trusts endorse each paper. Same corpus, a different order for every researcher.
- Sclerostin Is an Osteocyte-expressed Negative Regulator of Bone Formation, But Not a Classical BMP Antagonist (Journal of Experimental Medicine)
- Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. (New England Journal of Medicine)
- Osteocyte control of bone formation via sclerostin, a novel BMP antagonist (EMBO Journal)
- Sex steroids and the construction and conservation of the adult skeleton. (Endocrine reviews)
- LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. (Cell)
- An LDL-receptor-related protein mediates Wnt signalling in mice (Nature)
- Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. (American Journal of Human Genetics)
- Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor (Journal of Cell Biology)
- High bone density due to a mutation in LDL-receptor-related protein 5. (New England Journal of Medicine)
- LDL-receptor-related proteins in Wnt signal transduction (Nature)
Their papers
- WNT signaling in bone homeostasis and disease: from human mutations to treatments (2013) — 2,021 citations
- SOST is a target gene for PTH in bone. (2005) — 612 citations